6Kaufman JH,Tolpin DW. Glaucoma after traumatic angle recession:a tenyear prospective study[J]. Am J Ophthalmol, 1974,78(6):648-648.
7Heilmaun K, Bohhringer D, Reinhard T, et al. Glaucoma conceptions of a disease, pathogenesis, diagnosis, therapy [ M ]. New York : Thieme, 1978,381-383.
8Chandler PA, Grant WM. Glaucoma. 2ed. Philadelphia: Lea, 1979,194-196.
2Stejada M C,Nicolau A,Gamundí S Esteban. Effects of the muscarinic agonist pilocarpine on vigilance states and locomotor activity in ring doves[J].Physiology & Behavior,2012,(04):1007-1013.
3Yang Jui,Lai Ai-Ching,Hsieh. A gelatin-g-poly(Nisopropylacrylamide)biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine[J].Biomaterials,2012,(07):2372-2387.
4Ling Ling,WU Ping,HUANG Yan xiu. A 12-week,double-masked,parallel-group study of the safety and efficacy of travoprost 0.004％ compared with pilocarpine 1％ in Chinese patients with primary angle-closure and primary angle-closure glaucoma[J].Journal of Glaucoma,2011,(06):388-391.
5Hojung,Choi Youngwon,Lee Seongchan. Effects of anti-glaucoma drugs on resistive index of the medial long posterior ciliary artery using color Doppler imaging in Beagle dogs[J].Journal of Veterinary Science,2011,(01):99-101.
